Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalEtoposideHematopoietic Stem CellsThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHodgkin DiseaseHematopoiesisDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesNeoplasmsTissue DonorsSurvival RateWhole-Body IrradiationSurvival AnalysisTime FactorsInfectionLymphoma, T-CellDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountPrednisoneCarboplatinHistocompatibility TestingImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineFollow-Up StudiesBlood Cell CountRecombinant ProteinsBone Marrow PurgingLeukemiaAntineoplastic AgentsBlood Transfusion, AutologousLymphomaProspective StudiesBlood CellsCytomegalovirus InfectionsFeasibility StudiesFatal OutcomeGraft vs Leukemia EffectMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationT-LymphocytesLymphocyte DepletionLeukocytes, MononuclearHematologic DiseasesBone MarrowHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsLivedo ReticularisPrognosisHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaBreast NeoplasmsCyclosporineBlood DonorsImmunosuppressionCell SeparationMesenchymal Stem Cell Transplantation